Expression of DNA Topoisomerase II alpha and clinical significance in colon cancer.
DNA拓扑异构酶IIα在结肠癌中的表达及其临床意义。
基本信息
- 批准号:08671491
- 负责人:
- 金额:$ 1.47万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
(Basic study)DNA Topoisomerase II alpha, which catalyzes conformational changes of DNA, is closely involed in processes such as DNA replication, transcription, chromosomal condensation with the formation of transient double strand breaks during DNA TopoisomeraseII reaction. It has recentry been proposed that there is the role of TopoisomeraseII alpha in DNA repair. We analyze TopoII alpha activity during DNA repair phase caused by UV irradiation and antitumor drugs in human colon cancer cell(COLO32ODM) line useing an immunohistochemical approach. In studies on antitumor drugs, we compared TopoII alpha activity in the presence of VP-16 as inhibitors of DNA TopoisomeraseII with CDDP as giving other lesion in DNA.And we observed that it's activity is sighficantly increased in Colo32ODM administered CDDP alone but degrease in the presence of VP-16 and cmbination with CDDP.Serum depieted Colo32ODM colon cancer cell were irradiated with [UV light. Cytospin specimen of these cell were immunoc … More ytochemically stained Topo II alpha, Ki-67, apoptosis( TUNEL method). In order to observed DNA damage and synthesis, thymine dymer and BrdU were mesured simultaneously. After UV irradiation, Topo alpha expression was incresed gradually. These alterration was parallel to thinin dymer but not to Ki-67. These result suggested that Topoisomerase II alpha is involved in DNA repair not in proliferation during repair phase. Immunohistochemical staining of TopoisomeraseII alpha is a maker of cellular activity and site of DNA repair possibility a useful marker of cellular progression to other cell cycle antigen.(Clinical study)DNA topoisomerase II alpha (Topo II alpha) and Ki- 67 antigens in colon cancers from 51 pa-tients were investigated by an immunohi-stochemuical technique using monoclonal anti-Topo II alpha (8D2) and MIB-1 antibodies respectively. Positive cells of TopoII alpha and Ki-67 antigens were observed at progressive sites of all samples.Positive rates of their expressions were calculated as the number of positive cells/lOOOover cancer cells in the section.A posi-tive correlation was detected between Topo II alpha indices and Ki-67 indices (r=O.55).Although there was a relative tendency in Topo II alpha and histological grading, the-re was no significant difference and further examination is necessary for evaluation. It was suggested that Topo II alpha maybe useful as a proliferative marker for detecting colon cancer. Less
(基础研究)DNA拓扑异构酶IIα催化DNA的构象变化,与DNA复制、转录、染色体缩合等过程密切相关,在DNA拓扑异构酶II反应中形成瞬时双链断裂。已有研究表明,拓扑异构酶IIα在DNA修复中具有重要作用。我们用免疫组织化学方法分析了紫外线照射和抗癌药物诱导的人结肠癌细胞株(COLO32ODM)DNA修复过程中Topo IIα的活性。在抗肿瘤药物的研究中,我们比较了Vp-16作为DNA拓扑异构酶II抑制剂时的Topo IIα活性与其他DNA损伤时的CDDP。我们观察到,在Colo32ODM中单独使用CDDP时其活性显著增加,但在VP-16存在下并与CDDP结合时其活性降低。这些细胞的胞浆标本均为免疫…TOPO IIα、Ki-67、细胞凋亡(TUNEL法)染色增强。同时测定胸腺嘧啶二聚体和BrdU,观察DNA损伤和合成。紫外线照射后,Topoα表达逐渐增加。这些变化与Thin-dymer呈平行关系,而与Ki-67无关。这些结果表明,拓扑异构酶IIα参与DNA修复,而不是参与修复阶段的增殖。拓扑异构酶IIα的免疫组织化学染色是细胞活性和DNA修复位置的标志物,是细胞向其他细胞周期抗原进展的有用标志。临床研究分别用抗Topo IIα(8D2)和MIB-1的单抗对51例结肠癌组织中的DNA拓扑异构酶IIα(Topo IIα)和Ki-67抗原进行了检测。所有标本进展点均可见Topo IIα和Ki-67抗原阳性细胞,以阳性细胞数/肿瘤细胞数计算其阳性细胞数。Topo IIα指数与Ki-67指数呈正相关(r=0.55)。Topo IIα指数与组织学分级虽有相对趋势,但差异无统计学意义,有待进一步检验。提示Topo IIα可作为检测结肠癌的增殖标记物。较少
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
R.Makizumi: "Expression of DNATopoisomerase II alpha and Clinical Significant in Advanced Colon Cancer" The St.Marianna Medical Journal. Vol.25, No4. 315-322 (1997)
R.Makizumi:“DNA 拓扑异构酶 II α 的表达及其在晚期结肠癌中的临床意义”《圣玛丽安娜医学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
野崎久充, 山田恭司, 他: "大腸癌細胞株を用いた紫外線照射によるDNA障害時におけるTopoisomerase IIαの発現" 聖マリアンナ医科大学雑誌. 25. 273-283 (1997)
Hisamitsu Nozaki、Kyoji Yamada 等人:“结直肠癌细胞系中 UV 照射引起的 DNA 损伤期间拓扑异构酶 IIα 的表达”,圣玛丽安娜大学医学院杂志 25. 273-283 (1997)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
野崎久充,山田恭司,他: "大腸癌細胞株を用いた紫外線照射によるDNA障害時におけるTopoisomerase IIの発現" 聖マリアンナ医科大学雑誌. 25. 273-283 (1997)
Hisamitsu Nozaki、Kyoji Yamada 等人:“结直肠癌细胞系中紫外线照射引起的 DNA 损伤期间拓扑异构酶 II 的表达”,圣玛丽安娜大学医学院杂志 25. 273-283 (1997)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
牧角良二: "進行大腸癌におけるDNA Topoisomerase IIαの発現と臨床的意義" 聖マリアンナ医科大学雑誌. 25. 315-322 (1997)
Ryoji Makikado:“DNA 拓扑异构酶 IIα 在晚期结直肠癌中的表达和临床意义”圣玛丽安娜大学医学院杂志 25. 315-322 (1997)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H.Nozaki, K.Yamada, M.Iwasaki: "Studies on the Role of Human DNA Topoisomerase II alpha During DNA Repair Induced by Ultraviolet Light Irradiation." The St.Marianna Medical Journal. Vol.25, No4. 273-283 (1997)
H.Nozaki、K.Yamada、M.Iwasaki:“人类 DNA 拓扑异构酶 II α 在紫外线照射诱导的 DNA 修复过程中的作用研究”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YAMADA Kyoji其他文献
YAMADA Kyoji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YAMADA Kyoji', 18)}}的其他基金
An attempt to develop a novel system for transforming a wide variety of plant species without using the genetic recombination technique.
尝试开发一种不使用基因重组技术来转化多种植物物种的新系统。
- 批准号:
25660002 - 财政年份:2013
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Colon cancer therapy targeting specific charactetistics of tumor vessel.
针对肿瘤血管特定特征的结肠癌治疗。
- 批准号:
16591366 - 财政年份:2004
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Enhancement of Vitamin E Level in Oilseeds through Metabolic Engineering.
通过代谢工程提高油籽中的维生素 E 水平。
- 批准号:
14360003 - 财政年份:2002
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cellular and Molecular Breeding of Sesame.
芝麻的细胞和分子育种。
- 批准号:
09660003 - 财政年份:1997
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Elucidating Mechanisms of Therapy-Resistance to Interferon-alfa in Myeloproliferative Neoplasm Stem Cells
阐明骨髓增殖性肿瘤干细胞对干扰素-α的治疗耐药机制
- 批准号:
10736872 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Target the Dusp1 in Jak2 dependent myeloproliferative neoplasm (MPN) for curative treatment
针对 Jak2 依赖性骨髓增生性肿瘤 (MPN) 中的 Dusp1 进行治愈性治疗
- 批准号:
10655109 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Hypoxia-Inducible Factors and Neutrophil Heterogeneity in Myeloproliferative Neoplasm-Associated Venous Thrombosis
骨髓增生性肿瘤相关静脉血栓形成中的缺氧诱导因素和中性粒细胞异质性
- 批准号:
10740120 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Pancreatic parenchymal atrophy and immune mechanisms associated with pancreatic ductal epithelial neoplasm
胰腺实质萎缩及与胰腺导管上皮肿瘤相关的免疫机制
- 批准号:
23K14582 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Engineered microsystems to assess endothelial contribution to myeloproliferative neoplasm thrombosis
工程微系统评估内皮对骨髓增生性肿瘤血栓形成的贡献
- 批准号:
10674047 - 财政年份:2022
- 资助金额:
$ 1.47万 - 项目类别:
Selective pressures from inherited variation impacting myeloproliferative neoplasm initiation
遗传变异的选择性压力影响骨髓增生性肿瘤的发生
- 批准号:
10651876 - 财政年份:2022
- 资助金额:
$ 1.47万 - 项目类别:
Engineered microsystems to assess endothelial contribution to myeloproliferative neoplasm thrombosis
工程微系统评估内皮对骨髓增生性肿瘤血栓形成的贡献
- 批准号:
10524961 - 财政年份:2022
- 资助金额:
$ 1.47万 - 项目类别:
Selective pressures from inherited variation impacting myeloproliferative neoplasm initiation
遗传变异的选择性压力影响骨髓增生性肿瘤的发生
- 批准号:
10513391 - 财政年份:2022
- 资助金额:
$ 1.47万 - 项目类别:
Is the intra-tumoral microbiota involved in the progression of intraductal papillary mucinous neoplasm of the pancreas?
肿瘤内微生物群是否参与胰腺导管内乳头状粘液性肿瘤的进展?
- 批准号:
22K16514 - 财政年份:2022
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The establishment of an infrastructure for endocytoscopic (ultra-high magnifying endoscopic) diagnosis system to the colorectal neoplasm.
建立结直肠肿瘤内吞镜(超高放大内窥镜)诊断系统基础设施。
- 批准号:
21K15935 - 财政年份:2021
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists